AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2016
May 24, 2016
31676_dirs_2016-05-24_eaced10f-5aac-4af5-9c3e-1fe375461858.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2016-05-22
Reporting Person: Schrepfer Robert W (VP Bus Dev & Con Mfg)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-22 | Common Stock | F | 450 | $49.54 | Disposed | 29862 | Direct |
Footnotes
F1: Represents shares withheld by the Issuer to satisfy tax withholding obligation upon the vesting of 1,250 shares of restricted stock.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3